Plan in place to increase production of prefilled syringes for future COVID-19 vaccine

Health News

A deal for hundreds of millions of syringes that could be used to quickly administer a possible vaccine against COVID-19 has been reached between the U.S. government and a private company.

The $138 million partnership is with ApiJect Systems America, which makes inexpensive prefilled plastic syringes designed to be used in developing countries, NBC News reported.

The aim of the Project Jumpstart initiative is to produce 100 million prefilled syringes by the end of 2020 and more than 500 million in 2021 if a vaccine against COVID-19 becomes available, government officials said.

Source: Read Full Article

Related posts:
  1. Researchers look to next generation genetic sequencing for deeper understanding of COVID-19
  2. J&J vows to make 1 billion doses of coronavirus vaccine by 2021
  3. A diagnostic lung test to identify patients at high risk of COVID-19 complications